|
Volumn 10, Issue 3, 2004, Pages 234-235
|
Aurora kinases dawn as cancer drug targets
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AURORA A KINASE;
AURORA B KINASE;
AURORA KINASE;
CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE;
PHOSPHOTRANSFERASE;
UNCLASSIFIED DRUG;
CELL CYCLE PROTEIN;
ENZYME INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
ANTINEOPLASTIC ACTIVITY;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
MITOSIS;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
CELL DIVISION;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
METABOLISM;
NEOPLASM;
NOTE;
PHYSIOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE PROTEINS;
CELL DIVISION;
CLINICAL TRIALS;
ENZYME INHIBITORS;
HUMANS;
MITOSIS;
NEOPLASMS;
PROTEIN-SERINE-THREONINE KINASES;
|
EID: 2342593974
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0304-234 Document Type: Short Survey |
Times cited : (32)
|
References (10)
|